BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2301603)

  • 1. Beneficial effect of a platelet-activating factor antagonist, WEB 2086, on endotoxin-induced lung injury.
    Chang SW; Fernyak S; Voelkel NF
    Am J Physiol; 1990 Jan; 258(1 Pt 2):H153-8. PubMed ID: 2301603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-induced lung injury is not mediated by platelet-activating factor.
    Chang SW; Ohara N; Kuo G; Voelkel NF
    Am J Physiol; 1989 Oct; 257(4 Pt 1):L232-9. PubMed ID: 2801951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.
    Chang SW; Feddersen CO; Henson PM; Voelkel NF
    J Clin Invest; 1987 May; 79(5):1498-509. PubMed ID: 3553241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep.
    Christman BW; Lefferts PL; Blair IA; Snapper JR
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1272-8. PubMed ID: 2174655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
    Chang SW
    J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a new and specific PAF-antagonist, WEB 2086, on PAF and endotoxin/tumor necrosis factor induced changes in mortality and intestinal transit velocity.
    Heuer H
    Prog Clin Biol Res; 1989; 308():919-24. PubMed ID: 2780739
    [No Abstract]   [Full Text] [Related]  

  • 7. Endotoxin causes neutrophil-independent oxidative stress in rats.
    Chang SW; Lauterburg BH; Voelkel NF
    J Appl Physiol (1985); 1988 Jul; 65(1):358-67. PubMed ID: 3042743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock.
    Casals-Stenzel J
    Eur J Pharmacol; 1987 Mar; 135(2):117-22. PubMed ID: 3582490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FMLP causes eicosanoid-dependent vasoconstriction and edema in lungs from endotoxin-primed rats.
    Voelkel NF; Czartolomna J; Simpson J; Murphy RC
    Am Rev Respir Dis; 1992 Mar; 145(3):701-11. PubMed ID: 1546853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchial and vascular effects of Paf in the rat isolated lung are completely blocked by WEB 2086, a novel specific Paf antagonist.
    Casals-Stenzel J; Franke J; Friedrich T; Lichey J
    Br J Pharmacol; 1987 Aug; 91(4):799-802. PubMed ID: 3664079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nitric oxide and platelet-activating factor in the inhibition by endotoxin of pentagastrin-stimulated gastric acid secretion.
    Martinez-Cuesta MA; Barrachina MD; Piqué JM; Whittle BJ; Esplugues JV
    Eur J Pharmacol; 1992 Aug; 218(2-3):351-4. PubMed ID: 1385169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats.
    Qi M; Jones SB
    Circ Shock; 1990 Oct; 32(2):153-63. PubMed ID: 2253318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protective effect of a platelet activating factor antagonist in experimental liver injury].
    Zhang F
    Zhonghua Yi Xue Za Zhi; 1990 Jul; 70(7):375-8, 26. PubMed ID: 2171727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dibutyryl-cAMP blocks endotoxin-induced lung injury in rats.
    Chang SW; Sakai A; Voelkel NF
    Am Rev Respir Dis; 1989 Dec; 140(6):1814-7. PubMed ID: 2557788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased prostaglandin I2 and thromboxane A2 production by rat dental pulp after intravenous administration of endotoxin.
    Hirafuji M; Shinoda H
    Arch Oral Biol; 1994 Nov; 39(11):995-1000. PubMed ID: 7695514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]WEB 2086 labels platelet activating factor receptors in guinea pig and human lung.
    Dent G; Ukena D; Sybrecht GW; Barnes PJ
    Eur J Pharmacol; 1989 Oct; 169(2-3):313-6. PubMed ID: 2553451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity.
    Bouvier C; Guc MO; Furman BL; Parratt JR
    Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A PAF antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep.
    Solèr M; Sielczak MW; Abraham WM
    J Appl Physiol (1985); 1989 Jul; 67(1):406-13. PubMed ID: 2759969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
    Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.